“We are working on specific measures that we can take in the short, medium and long term,” a joint statement from London and Brussels said.
The European Union and Great Britain, while expressing disagreement over the management of the stock of vaccines produced in Europe by the Anglo-Swedish group AstraZeneca, on Wednesday assured their intention to settle this important dispute by negotiation.
With “a very serious epidemiological situation”, the European Union “continues to export significant amounts to countries producing their own vaccines or is already getting their populations vaccinated widely, first Wednesday Was regretted by the Deputy Chairman of the Commission, Vallaris Dombrovsky.
He was referring to the fact that the EU exported some 10 million doses of all vaccines to the UK, but despite the contract signed by AstraZeneca for the delivery of doses from two UK factories, any dose produced across the channel Not received in exchange for.
The company had explained that it was necessary to honor British orders as a priority for its contract with London.
The EU’s “mass exports” but “roads must be taken both ways,” warned Commission Chairman Ursula von der Laden.
Facing this situation, the European Executive adopted two adjustments “to address these imbalances” to the current mechanism of export imbalances and to “guarantee” supply of Twenty-Seven, announced Mr. Dombrovsky.
Mutually beneficial position
These measures were quickly condemned by British Prime Minister Boris Johnson, warning them of the consequences of investing in Kovid’s “arbitrary blocking” of anti-vaccines.
“I think that vaccines or vaccine material blockages are a sensitive subject,” Boris Johnson insisted, adding that the vaccines were the result of “international cooperation”.
Negotiations between Brussels and London had begun, resulting in a joint declaration on Wednesday: EU and English officials indicated they were working to find a “mutually beneficial” solution to resolve these tensions .
“In view of our interdependencies in the production of vaccines,” we are working on specific measures that we can take in the short term, medium and long term, to reach a mutually beneficial position and increase the supply of vaccines for our citizens . , Said London and Brussels in a joint statement.